Gileyna significantly reduces relapses in children...

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Gileyna significantly reduces relapses in children...

Post by MSUK » Tue Sep 05, 2017 2:51 am

Phase III trial shows Gileyna significantly reduces relapses in children and adolescents with MS

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as fingolimod) versus interferon beta-1a...Read more - http://www.ms-uk.org/phase-iii-trial-sh ... escents-ms
MS-UK - http://www.ms-uk.org/

User avatar
NHE
Volunteer Moderator
Posts: 5177
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: Gileyna significantly reduces relapses in children...

Post by NHE » Tue Sep 05, 2017 10:34 pm

MSUK wrote:Phase III trial shows Gileyna significantly reduces relapses in children and adolescents with MS

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as fingolimod) versus interferon beta-1a...Read more - http://www.ms-uk.org/phase-iii-trial-sh ... escents-ms
But does it reduce progression of disability? That's what really counts.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post